 |
|
Resistència a la insulina Barker DJP, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986; i:1077-1081. Barker DJP, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989; ii: 577-580. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS. Type 2 (non-insulin-dependent) diabetismellitus, hypertension, and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-67. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetismellitus and hypertension. Nature 1999;402:880-883. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 236: E667-E677, 1979 Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity in-dex in man derived by the minimal model method and euglycaemic glucose clamp. J Clin Invest 1987; 79:790-800. Bjorntorp P, Rosmond R. Neuroendocrine abnormalities in visceral obesity. Int J Obes Relat Metab Disord 2000; 24 Suppl 2:S80-S85. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven GM. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985; 248: E286-291. Bonadonna RC, Groop LC, Zych K, Shank M, DeFronzo RA. Dose-dependent effect of insulin on plasma free fatty acid turnover oxidation in humans. Am J Physiol 1990; 259: E736-E750. Bonora E, Moghetti P, Zancanaro C. et al. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycaemic and hyperglucaemic clamp studies. J Clin Endocrinol Metab 1989; 68:374-78. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp tecnique in the assessment of insulin sensitivity. diabetisCare 2000; 23: 57-63. Bouchard C, Tremblay A, Despres JP, Nadeau A, Lupien PJ, Theriault G, Dussault J, Moorjani S, Pinault S, Fournier G. The response to long-term overfeeding in identical twins. N Engl J Med 1990; 322:1477-1482. Brand E, Schorr U, Kunz I, Kertmen E, Ringel J, Distler A, Sharma AM. 2001 Tumor necrosis factor alpha –308 G/A polymorphism in obese Caucasians. Int J Obes Relat Metab Disord 25: 581-585 Brand Miller JC, Colagiuri S. The carnivore connection: dietary carbohydrate in the evolution of NIDDM. Diabetologia 1994; 37: 1280-1286. Caumo A, Bergman RN, Cobelli C. Insulin sensitivity from meal tolerance test in normal subjects: A minimal model index. J Clin Endocrinol Metab 2000; 85:4396-402. Cavallo-Perin P, Cassader M, Bozzo C, Bruno A, Nuccio P, Dall'Omo AM, Marucci M, Pagano G. Mechanisms of insulin resistance in human liver cirrhosis. Evidence of a combined receptror and postreceptor defect. J Clin Invest 1985; 75: 1659-1665. Cavallo-Perin P, Pacini G, Cerutti F, Bessone A, Condo C, Sacchetti L, Piga A, Pagano G. Insulin Resistance and Hyperinsulinemia in Homozygous Chen Y-DI, Golay A, Swislocki ALM, Reaven GM. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetismellitus. J Clin Endocrinol Metab 1987; 64: 17-21. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetismellitus: the STOP-NIDDM randomised trial. Lancet 2002; 359:2072-2077. Clausen JO, Hansen T, Bjørbaek C, Echwald SM, Urhammer SA, Rasmussen S, Andersen CB, Hansen L, Almind K, Winther K, Haraldsdòttir J, Borch-Johnsen K, Pedersen O. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 1995; 346:397-402). Clement K, Vaisse C, Manning BS, Basdevant A, Guy-Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, Strosberg AD. Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333:352-354. Clement K, Garner C, Hager J, Philippi A, Due CL, Carey A, Harris T, Jury C. Indication Clement K, Philippi A, Jury C, Pivdal R, Hager J, Demenais F, Basdevant A, Guy-Grand B. Candidate gene approach of familial morbid obesity-linkage analysis of the glucocorticoid receptor gene. Int J Obes 1996; 20:507-512. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID. 2002 Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 10: 401-407 Dandona P, Hussain MAM, Varghese Z, Politis D, Flynn DM, Hoffbrand AV. Insulin resistance and iron overload. Ann Clin Biochem 1983; 20:77-79. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20:284-287. DeFronzo RA, Soman V, Sherwin RT, Hendler R, Felig P. Insulin binding to monocytes and insulin action in human obesity, starvation and refeeding. J Clin Invest 1978; 62: DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223, 1979 Deriaz O, Dionne F, Perusse L, Tremblay A, Vohl MC, Cote G, Bouchard C. DNA variation in the genes of the Na,K-adenosine triphosphatase and its relation with resting metabolic rate, respiratory quotient, and body fat. J Clin Invest 1994; 93:838-843. Dmochowski K, Finegood DT, Francombe W, Tyler B, Zinman B. Factors determining Duggirala R, Stern M, Mitchell L, Reinhart LJ, Shipman PA, Uresandi OC, Chung WK, Leibel RL, Hales CN, O'Connell P, Blangero J. Quantitative variation in obesity related traits and insulin precursers linked to ob gene region on human chromosome 7. Am J Hum Genet 1996; 59: 694-703. Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J: A simple measure of insulin resistance. Lancet 346:120-121, 1995 Eckel RH. Insulin Resistance: an adaptation for weight maintenance. Lancet 1992; 340: 1452-1453. Eriksson JG, Forsen T, Tuomilehto J, Osmond C, Barker DJ. Early growth and coronary heart disease in later life: longitudinal study. BMJ 2001;322:949-953. Fernández-Real JM, Gutierrez C, Ricart W, Casamitjana R, Vendrell J, Fernández-Castañer M, Richart C, Soler J. The TNF-
Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, Hernández-Aguado I, Ricart W. Blood letting in high ferritin type 2 diabetismellitus. Effects on insulin sensitivity and Finch CA, Huebers H. Perspectives in iron metabolism. N Engl J Med 1982; 306:1520-1528. Flier JS, Kahn CR, Roth J, Bar RS. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 1975; 190: 63-65. Foley JE. Rationale and application of fatty acid oxidation inhibitors in treatment of dia-betes mellitus. diabetisCare 1992; 15: 773-781. Fraze E, Donner CC, Swislocki ALM, Chiou Y-AM, Chen Y-DI, Reaven GM. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetismellitus: evidence for insulin resistance. J Clin Endocrinol Metab 1985; 61: 807-811. Freeman DJ, Norrie J, Sattar N, Neely RD, Cobbe SM, Ford I, Isles C, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ, Shepherd J, Gaw A. Pravastatin and the development of diabetismellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 2001; 103: 357-362. Golay A, Swislocki ALM, Chen Y-DI, Reaven GM. Relationship between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism 1987; 36:692-696. Hager SR. Insulin resistance of uremia. Am J Kidney Dis 1989; 14: 272-276. Hale PJ, Wright JV, Nattrass M. Differences in insulin sensitivity between normal men and women. Metabolism 1985; 34:1133-1138. Hales CN, Barker DJP, Clark PMS, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 1991; 303: 1019-1022. Hales CN, Barker DJP. Type 2 (non-insulin-dependent) diabetismellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-601. Heo M, Leibel RL, Fontaine KR, Boyer BB, Chung WK, Koulu M, Karvonen MK, Pesonen U, Rissanen A, Laakso M, Uusitupa MI, Chagnon Y, Bouchard C, Donohoue PA, Burns TL, Shuldiner AR, Silver K, Andersen RE, Pedersen O, Echwald S, Sorensen TI, Behn P, Permutt MA, Jacobs KB, Elston RC, Hoffman DJ, Gropp E, Allison DB. A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index and waist circumference. Int J Obes Relat Metab Disord 2002; 26:640-646. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, Cambien F. 1998 Polymorphisms of the tumour necrosis factor- Hitman GA, McCarthy MI. Genetics of non-insulin dependent diabetismellitus. Clin Endocrinol Metab 1991; 5:455-476. Ho LT, Chang ZY, Wang JT, Li SH, Liu YF, Chen YD, Reaven GM. Insulin insensitivity in offspring of parents with type 2 diabetismellitus. Diabet Med 1990; 7: 31-34. Hoffstedt J, Eriksson P, Hellstrom L, Rossner S, Rydén M, Arner P. 2000 Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia 43:117-120 Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987; 64: 1169-1173. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased Adipose Tissue Expression of Tumor Necrosis Factor- Hukshorn CJ, van Dielen FM, Buurman WA, Westerterp-Plantenga MS, Campfield LA, Saris WH. The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects. Int J Obes Relat Metab Disord 2002; 26:504-509 Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 2002; 109:1321-1326 Hunt MS, Katzmarzyk PT, Perusse L, Rice T, Rao DC, Bouchard C. Familial resemblance of 7-year changes in body mass and adiposity. Obes Res 2002; 10:507-517. Imbeault P, Prins JB, Stolic M, Russell AW, O'Moore-Sullivan T, Despres JP, Bouchard C, Tremblay A. Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence. diabetisCare 2003; 26:480-484. Ishii T, Hirose H, Saito I, Nishikai K, Maruyama H, Saruta T. 2000 Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men. Metabolism 49:1616-1618 Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K. 1999 Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetismellitus: a placebo-controlled pilot trial. Free Radic Biol Med 27:309-314 Jeng C-Y, Sheu WH-H, Fuh MM-T, Cheng Y-DI, Reaven GM. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with non-insulin-dependent diabetismellitus. diabetis1994; 48: 1440-1444. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J. The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disorders in man. N Engl J Med 1976; 294: 739-745. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity in Humans. J Clin Endocrinol Metab 2000; 85:2402-10. Kim J, Kim Y-J, Fillmore J, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE, Shulman GI. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001; 108:437-446 Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation of obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-2119. Kieffer TJ, Heller RS, Habener JF. Leptin receptors expressed on pancreatic beta-cells. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetiswith lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403. Krotkiewski M, Björntorp P, Sjöström L, Smith U. Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest 1983; 72:1150-1162. Laws A, Stefanick ML, Reaven GM. Insulin resistance and hipertriglyceridemia in nodiabetic relatives of patients with noninsulin-dependent diabetismellitus. J Clin Endocrinol Metab 1989; 69: 343-347. Lönnqvist F, Thörne A, Nilsell K, Hoffstedt J, Arner P. A pathogenetic role of visceral Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. diabetisCare 2001; 24:539-48. Mårin P, Darin N, Amemiya T, Andersson B, Jern S, Björntorp P. Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 1992; 41: 882-886. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Comparison with the euglycemic insulin clamp. diabetisCare 1999;22:1462-70. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment; insulin resistance and Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, Tamborlane WV. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 1988; 318: 809-814. Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997; 349: 95-97. Moller DE, Flier JS. Insulin resistance. Mechanisms, syndromes, and implications. N Engl J Med 1991; 325: 938-947. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387:903-908. Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in iso- Neel JV. diabetismellitus: A "thrifty" genotype rendered detrimental by "progress?". Am J Hum Genet 1962; 14: 353-362. Niederau C, Berger M, Stremmel W, Starke A, Strohmeyer G, Ebert R, Siegel E, Nuutila P, Knuuti J, Mäki M, Laine H, Ruotsalainen U, Teräs M, Haaparanta M, Solin O, Yki-Järvinen H. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. diabetis1995; 44:31-36. Olefsky J. Treatment of insulin resistance with peroxisome proliferator-activated receptor Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetisStudy. diabetisCare 1997; 20:537-544. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, Labate AM, Barbara L. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993; 77: 341-346. Peiris AN, Struve MF, Mueller RA, Lee MB, Kissebah AH. Glucose metabolism in obesity: influence of body fat distribution. J Clin Endocrinol Metab 1988; 67: 760-767. Peters JM, Barnes R, Bennett L, Gitomer WM, Bowcock AM, Garg A. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat Genet 1998;18:292-295. Phelps G, Hall P, C I, Braund W, McKinnon M. Prevalence of genetic haemochromatosis among diabetic patients. Lancet 1989; i:233-234. Rabson SM, Mendenhall EN. Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetismellitus: report of 3 cases. Am J Clin Pathol 1956; 26: 283-290. Rankinen T, Perusse L, Weisnagel SJ, Snyder EE, Chagnon YC, Bouchard C. The human obesity gene map: the 2001 update. Obes Res 2002;10:196-243. Reaven GM. Banting Lecture 1988: Role of insulin resistance in human disease. diabetis1988; 37:1595-1607. Reaven GM, Hollenbeck CB, Chen Y-DI. Relationship between glucose tolerance, in-sulin secretion, and insulin action in non-obese individuals with vaying degrees of glu-cose tolerance. Diabetologia 1989; 32: 52-55. Reaven GM, Brand RJ, Chen Y-DI, Mathur AK, Goldfine I. Insulin resistance and insu-lin secretion are determinants of oral glucose tolerance in normal individuals. diabetis1993; 42: 1324-1332. Rebrin K, Steil GM, Mittelman SD, Bergman RN. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 1996; 98: 741-749. Rosenson RS, Tangney CC, Casey LC. 1999 Inhibition of proinflammatory cytokine production by pravastatin. Lancet 353: 983-984 Rosenthal M, Haskell WL, Solomon R, Widström A, Reaven GM. Demonstration of a relationship between physical training and insulin-stimulated glucose utilization in normal humans. diabetis1983; 32:408-411. Rosmond R. The glucocorticoid receptor gene and its association to metabolic syndrome. Obes Res. 2002;10:1078-1086. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, DE, Porte Jr D, Woods SC, Seeley RJ, Weigle DS. Specificity of leptin action on elevated glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice.
Serrano Rios M, Ascaso Gimilio JF, Blazquez Fernandez E, Cabezas Cerraro J, Carmena Rodriguez R, Escobar Jimenez F, Fernandez-Real JM, Gabriel Sanchez R, Gomis de Barbera R, Grande Aragon C, Herrera Pomba JL, Pallardo Sanchez LF, Potau Vilalta N, Ricart Engel W, Rovira Loscos A, Zorzano Olarte A; Grupo de Trabajo Resistencia a la insulina de la Sociedad Espanola de Diabetes. Resistencia a la insulina y su implicación en múltiples factores de riesgo asociados a diabetistipo 2. Medicina Clínica 2002; 119: 458-463. Shafer AI, Cheron RG, Dluhy R , Cooper B, Gleason RE, Soeldner JS, Bunn HF: Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 1981; 304:319-324. Shen S-W, Reaven GM, Farquhar JW. Comparison of impedance to insulin mediated glucose uptake in normal and diabetic subjects. J Clin Invest 1970; 49: 2151-2160. Simon M, Bourel M, Genetat B, Fauchet R. Idiopathic hemochromatosis. N Engl J Med 1977; 297:1017-1021. Sivitz WI, Walsh SA, Morgan DA, Thomas MJ, Haynes WG. Effects of leptin on insulin Skowronski R, Hollenbeck CB, Varasteh BB, Chen Y-DI, Reaven GM. Regulation of non-esterified fatty acid and glycerol concentration by insulin in normal individuals and patients with type 2 diabetes. Diabet Med 1991; 8: 330-333. Slag MF, Ahmed M, Gannon MC, Nutall FO. Meal stimulation of cortisol secretion: a protein induced effect. Metabolism 1981; 30: 1104-1108. Smith U, Hammersten J, Björntorp P, Kral J. Regional difference and effect of weight reduction on human fat cell metabolism. Eur J Clin Invest 1979; 9: 327-333. Speckman RA, Garg A, Du F, Bennett L, Veile R, Arioglu E, Taylor SI, Lovett M, Bowcock AM. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet 2000;66:1192-1198. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 2001; 104:531-543. Stern MP. diabetisand cardiovascular disease. The "common soil" hypothesis. diabetis1995; 44: 369-374 Swinburn BA, Nyomba BL, Saad MF, Zurlo F, Raz I, Knowler WC, Lillioja S, Bogardus C, Ravussin E. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991; 88: 168-173. Swislocki ALM, Chen Y-DI, Golay A, Chang M-O, Reaven GM. Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia 1987; 30: 622-626. Taylor SI, Barr V, Reitman M. Does leptin contribute to diabetiscaused by obesity? Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetismellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:1343-1350. UKPDS [No authors listed] Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetis(UKPDS 34). UK Prospective diabetisStudy (UKPDS) Group. Lancet 1998;352:854-865. United States Department of Health, Education, and Welfare. Ten State Nutrition Survey, 1968-1970. Washington, D.C.: Government printing Office, 1972. Vague J. La differentiation sexuelle. Facteur determinant des formes de l'obesité. Presse Med 1947; 55:339. Valdez R, Athens MA, Thompson GH, Bradshaw BS, Stern MP. Birth weight and adult health outcomes in a biethnic U.S. population. Diabetologia 1994; 37: 624-631. Valenti L, Fracanzani AL, Dongiovanni P, Santorelli G, Branchi A, Taioli E, Fiorelli G, Fargion S. 2002 Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology 122:274-280 Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet 1999; 354:141-148. Vidal-Puig A, Bjorbaek C. Genética molecular de la diabetismellitus no insulino-dependiente. Med Clin 1997; 109: 107-114. Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, Manning B, Strosberg AD, Stern MP, Raben N, Sorkin JD, Roth J, Shuldiner AR. Time of onset of non-insulin-dependent diabetismellitus and genetic variation in the Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348-351. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T,Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C,Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946 Yki-Järvinen H, Koivisto VA. Effect of body composition on insulin sensitivity. diabetis1983; 32:965-969. Yki-Järvinen H. Acute and chronic effects of hyperglycemia on glucose metabolism. Diabetologia 1990; 33:579-585. Yki-Järvinen H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 1995; 38:1378-1388. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li Z-W, Karin M, Shoelson SE. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkß. Science 2001; 293: 1673-1677 Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. 2000 Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:145-153 Zhou Y-P, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 1994; 93: 870-876. |
|
[subir]
|
-Thalassemia. Metabolism 1995; 44: 281-286.
Nco I polymorphism influences the relationship among insulin resistance, percent body fat and increased serum leptin levels. diabetis1997; 46: 1468-1472
agonists. J Clin Invest 2000; 106:467-472.